Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Atsuhito Tone"'
Autor:
Akira Okada, Akiko Suganuma, Ken Kato, Atsuhito Tone, Moritsugu Kimura, Satoshi Kawashima, Tomokazu Watanabe, Hideaki Sawaki, Shinsuke Nirengi, Naoki Sakane, Munehide Matsuhisa, Akio Kuroda, Takashi Murata, Masao Toyoda, Yushi Hirota
Publikováno v:
Diabetes Technology & Therapeutics. 22:216-221
Background: Continuous subcutaneous insulin infusion (CSII) is associated with improved glycemic control, a reduced incidence of hypoglycemia, and improved quality of life (QOL). To date, however, ...
Autor:
Kenichi Shikata, Akihiro Katayama, Sanae Teshigawara, Jun Wada, Jun Eguchi, Atsuko Nakatsuka, Atsuhito Tone, Satoshi Miyamoto, Mayu Watanabe
Publikováno v:
Diabetol Int
Aims/introduction The predictive low glucose management (PLGM) system was introduced in March 2018 in Japan. Although there are some reports demonstrating the benefit of PLGM in preventing hypoglycemia, no data are currently available in Japanese pat
Autor:
Atsuhito Tone, Shinichiro Ando, Takashi Matsuoka, Tatsuaki Nakato, Kazutoshi Murakami, Akihiro Katayama, Chigusa Higuchi, Haruhito A. Uchida, Atsuko Nakatsuka, Tomokazu Nunoue, Mayu Watanabe, Koki Mise, Sanae Teshigawara, Kenichi Shikata, Satoshi Miyamoto, Jun Eguchi, Satoshi Yamaguchi, Michihiro Yoshida, Katsuhiro Miyashita, Kazuyuki Hida, Masao Yamada, Jun Wada, Shinji Kamei, Mariko Imamura, Ikki Shimizu
Publikováno v:
Frontiers in Cardiovascular Medicine, Vol 8 (2021)
Frontiers in Cardiovascular Medicine
Frontiers in Cardiovascular Medicine
Background: Although various biomarkers predict cardiovascular event (CVE) in patients with diabetes, the relationship of urinary glycan profile with CVE in patients with diabetes remains unclear.Methods: Among 680 patients with type 2 diabetes, we e
Autor:
Moritsugu Kimura, Hideaki Sawaki, Ken Kato, Naoki Sakane, Akira Okada, Satoshi Kawashima, Tomokazu Watanabe, Akiko Suganuma, Atsuhito Tone, Masao Toyoda, Akio Kuroda, Takashi Murata, Shinsuke Nirengi, Yushi Hirota, Munehide Matsuhisa
Publikováno v:
J Diabetes Sci Technol
Background: Information about factors related to better adherence to continuous glucose monitoring (CGM) sensor adherence is quite limited. Materials and Methods: Forty-six participants with type 1 diabetes using continuous subcutaneous insulin infus
Autor:
Sanae Teshigawara, Atsuko Nakatsuka, Haruhito A. Uchida, Atsuhito Tone, Michihiro Yoshida, Kenichi Shikata, Jun Wada, Masao Yamada, Satoshi Yamaguchi, Mariko Imamura, Jun Eguchi, Daisuke Ogawa, Koki Mise
Publikováno v:
Diabetes Care. 41:1765-1775
OBJECTIVE Because quantifying glycans with complex structures is technically challenging, little is known about the association of glycosylation profiles with the renal prognosis in diabetic kidney disease (DKD). RESEARCH DESIGN AND METHODS In 675 pa
Autor:
Miho Tsuruo, Kenji Kamiuchi, Hideaki Sawaki, Akiko Suganuma, Moritsugu Kimura, Masao Toyoda, Naoki Sakane, Satoshi Kawashima, Kensou Osawa, Takashi Murata, Ryuji Kouyama, Ken Kato, Kohshi Narasaki, Atsuhito Tone, Tomokazu Watanabe
Publikováno v:
Internal Medicine
Objective We compared the pain accompanying the injection of high-concentration (300 units/mL) insulin glargine (U300G) with that accompanying the injection of conventional (100 units/mL) insulin glargine (U100G). Methods U100G was switched to U300G
Autor:
Akira Okada, Yushi Hirota, Naoki Sakane, Akio Kuroda, Takashi Murata, Munehide Matsuhisa, Moritsugu Kimura, Ken Kato, Akiko Suganuma, Tomokazu Watanabe, Hideaki Sawaki, Satoshi Kawashima, Atsuhito Tone, Masao Toyoda
Publikováno v:
Diabetes. 68
Continuous subcutaneous insulin infusion (CSII) is associated with improved glycemic control, reduced incidence of hypoglycemia and improved quality of life (QoL). To date, however, there is no QoL scale specific to CSII. The objective of this study
Autor:
Motonobu Nishimura, Hideki Taki, Kazunori Yamada, Yutaka Ando, Tsuyoshi Tanaka, Seiji Suzuki, Atsuhito Tone, Yoshiharu Hoshiyama, Miho Saito, Yasuhisa Kato
Publikováno v:
American journal of hypertension. 30(8)
BACKGROUND The Home Blood Pressure for Diabetic Nephropathy study is a prospective observational study conducted to determine the effect of home blood pressure (HBP) on remission/regression of microalbuminuria in patients with type 2 diabetes mellitu
Publikováno v:
Journal of Diabetes Science and Technology. 12:729-730
Autor:
Y. Kato, Izumi Iseda, N. Nagase, M. Kato, M. Nishimura, K. Higashi, R. Todo, H. Yoshizumi, F. Shimada, Y. Ando, Atsuhito Tone, Y. Hoshiyama, Kazuyuki Hida
Publikováno v:
Diabetology International. 2:10-18
Controlling hypertension has been revealed to be as important as controlling hyperglycemia to prevent the progression of diabetic nephropathy. Home blood pressure (HBP) measurement is useful for the treatment of hypertension. This study aimed to dete